Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nutricia Recalls Neocate Infant Product
Nutricia North America has contacted customers to undertake the voluntary recall and replacement of one lot of the specialised infant formula product, Neocate. This recall involves a limited
Nutricia North America has contacted customers to undertake the voluntary recall and replacement of one lot of the specialised infant formula product, Neocate. This recall involves a limited
Flexible Stenting Solutions (FSS) has received Conditional Investigational Device Exemption (IDE) approval for its FlexStent Femoropopliteal Self Expanding Stent System. FSS is now authorized to begin its US
The Chinese Patent Office has issued Nutraceutix, patent no 02823678.5 for BIO-tract. The company said that the technology has been awarded based on BIO-tract’s ability to protect sensitive
Inspirion Delivery Technologies (IDT) has announced that last week the company completed a pre-investigational new drug (Pre-IND) meeting with the FDA to determine the clinical and regulatory pathway
Based on feasibility trials of the CONSIGMA, a shear granulation and drying system, in the process development center of GEA Pharma Systems nv – Collette, another Mexican generic
Abbott Laboratories has reportedly joined the bidding war for Solvay Pharma with the highest offer so far of between E4.5 billion and E5 billion. A fully financed previous
Ampac Fine Chemicals (AFC) has successfully qualified, validated and installed a continuous extraction process in a cGMP manufacturing environment, reported Processingtalk. Reportedly, the company made the modification with
As the pharmaceutical industry is experiencing an economic turn down, the pharma giant meet to the discuss pharmaceutical futures. The pharma giants, GSK, Bayer, AstraZeneca, Novartis and Pfizer
With higher disposable incomes and changing attitudes towards healthcare, Indian consumers are buying more over-the-counter (OTC) drugs than before. While the total domestic OTC market size at INR21
YM BioSciences has reported total revenue of $5.6m for the fiscal year ended June 30, 2009, a decrease in comparison with $7.4m for fiscal year 2008. Fourth quarter